Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Milestone Scientific (MLSS)

  • Business News
  • Jan. 06, 2026, 13:30 UTC
  • 2
  • 1 comments

Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry

Market reaction Comment Full text

LifeMD Inc (LFMD)

  • Business News
  • Jan. 06, 2026, 13:30 UTC
  • 4
  • 1 comments

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.

Market reaction Comment Full text

FibroBiologics, Inc. (FBLG)

  • Business News
  • Jan. 06, 2026, 13:30 UTC
  • 2
  • 1 comments

FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference

Market reaction Comment Full text

GeneDx Holdings (WGSWW)

  • Business News
  • Jan. 06, 2026, 13:30 UTC
  • 2
  • 1 comments

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

Market reaction Comment Full text

Vericel Corporation (VCEL)

  • Business News
  • Jan. 06, 2026, 13:30 UTC
  • 2
  • 1 comments

Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026

Market reaction Comment Full text

CVRx Inc. (CVRX)

  • Business News
  • Jan. 06, 2026, 13:30 UTC
  • 2
  • 1 comments

CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy

Market reaction Comment Full text

Coeptis Therapeutics Holdings Inc (COEP)

  • Business News
  • Jan. 06, 2026, 13:19 UTC
  • 4
  • 1 comments

Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared

Market reaction Comment Full text

Eterna Therapeutics Inc (ERNA)

  • Business News
  • Jan. 06, 2026, 13:15 UTC
  • 6
  • 1 comments

Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer

Market reaction Comment Full text

Atossa Therapeutics Inc. (ATOS)

  • Business News
  • Jan. 06, 2026, 13:15 UTC
  • 7
  • 1 comments

Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer

Market reaction Comment Full text

Nuwellis Inc. (NUWE)

  • Business News
  • Jan. 06, 2026, 13:15 UTC
  • 6
  • 1 comments

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Market reaction Comment Full text
  • Previous
  • 156
  • 157
  • 158
  • 159
  • 160
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124509)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin